tiprankstipranks
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market

Soleno Therapeutics (SLNO) Financial Statements

Compare
727 Followers

Soleno Therapeutics Financial Overview

Soleno Therapeutics's market cap is currently $2.10B. The company's EPS TTM is $-4.26; its P/E ratio is ―; Soleno Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -1.96M$ -2.21M$ -2.21M$ -2.19M
Operating Income$ 0.00$ -41.38M$ -24.40M$ -31.53M$ -36.29M
EBITDA$ 0.00$ -37.03M$ -21.86M$ -28.70M$ -30.00M
Net Income$ -175.85M$ -38.99M$ -20.32M$ -29.56M$ -15.38M
Balance Sheet
Cash & Short-Term Investments$ 291.44M$ 169.68M$ 14.60M$ 21.30M$ 49.22M
Total Assets$ 330.97M$ 180.69M$ 26.50M$ 35.55M$ 64.98M
Total Debt$ 3.00M$ 403.00K$ 155.00K$ 457.00K$ 139.00K
Net Debt$ -84.93M$ -169.28M$ -14.45M$ -20.85M$ -49.09M
Total Liabilities$ 85.86M$ 23.18M$ 16.15M$ 17.76M$ 19.43M
Stockholders' Equity$ 245.11M$ 157.51M$ 10.35M$ 17.79M$ 45.55M
Cash Flow
Free Cash Flow$ -69.31M$ -24.94M$ -20.79M$ -27.79M$ -25.23M
Operating Cash Flow$ -69.10M$ -24.94M$ -20.78M$ -27.77M$ -25.22M
Investing Cash Flow$ -225.68M$ 0.00$ -13.00K$ -22.00K$ -7.00K
Financing Cash Flow$ 213.03M$ 180.02M$ 14.09M$ -128.00K$ 53.72M
Currency in USD

Soleno Therapeutics Earnings and Revenue History

Soleno Therapeutics Debt to Assets

Soleno Therapeutics Cash Flow

Soleno Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis